During the past decade, UCLA, Integrated Substance Abuse Programs conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA, Integrated Substance Abuse Programs" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 6 trials as a collaborator, "Children's Hospital Los Angeles" with 1 trials as a collaborator, "The Emmes Company, LLC" with 1 trials as a collaborator, "University of California, Los Angeles" with 1 trials as a collaborator and "eHealth International, INC." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UCLA, Integrated Substance Abuse Programs" are "Amphetamine-Related Disorders" (3 trials), "Cocaine-Related Disorders" (3 trials), "Depression" (2 trials), "Alcohol Dependence" (1 trials) and "Alcohol-Related Disorders" (1 trials). Many other conditions were trialed in "UCLA, Integrated Substance Abuse Programs" in a lesser frequency.

Most popular intervention types in "UCLA, Integrated Substance Abuse Programs" are "Drug" (9 trials), "Behavioral" (8 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bupropion" (2 trials), "Aripiprazole" (1 trials), "Behavior Therapy" (1 trials) and "BrainWeighve App" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA, Integrated Substance Abuse Programs" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UCLA, Integrated Substance Abuse Programs". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in UCLA, Integrated Substance Abuse Programs, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA, Integrated Substance Abuse Programs, 7 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".